awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43492386-2B1B7203-5F7C-4589-8326-2E604DDABE0B
Q43492386-2B1B7203-5F7C-4589-8326-2E604DDABE0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43492386-2B1B7203-5F7C-4589-8326-2E604DDABE0B
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
P478
Q43492386-2B1B7203-5F7C-4589-8326-2E604DDABE0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43492386-2B1B7203-5F7C-4589-8326-2E604DDABE0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
459a8613dfc757ad17ff39054b608d4e5242fc82
P478
92
http://www.w3.org/2001/XMLSchema#string